Baroreflex mechanisms in major depression

Dmitry M Davydov1, David Shapiro, Ian A Cook

  • 1Department of Neurophysiology, Moscow Research Center of Narcology, 156-3-68 Leninsky pr-t, Moscow 117571, Russia. d.m.davydov@gmail.com

Insights

Depression impairs baroreflex sensitivity, affecting both afferent and efferent pathways. This autonomic dysfunction in major depressive disorder may increase cardiac mortality risk.

Area of Science:

  • Cardiology
  • Psychiatry
  • Autonomic Neuroscience

Background:

  • Depressive disorder is linked to impaired baroreflex sensitivity, a potential risk factor for sudden cardiac death.
  • Previous studies have not fully examined baroreflex loop components or regulatory mechanisms impacting cardiac function in depression.
  • This study aims to elucidate autonomic functioning in depression to understand increased cardiac mortality.

Purpose of the Study:

  • To investigate autonomic functioning in patients with major depressive disorder.
  • To examine baroreflex sensitivity and its afferent and efferent components in depression.
  • To explore the relationship between depression, autonomic dysfunction, and cardiac risk.

Main Methods:

  • Compared 28 depressed patients (in partial remission, on antidepressants) with 28 healthy controls.
  • Assessed negative affective dispositions, baroreflex activity, heart rate, heart rate variability, blood pressure, and double product.
  • Analyzed spontaneous (closed-loop) baroreflex activity under resting conditions.

Main Results:

  • Depressed patients exhibited higher sympathetic activity (elevated blood pressure, low-frequency heart rate variability) and lower parasympathetic activity (higher heart rate, reduced high-frequency heart rate variability).
  • Baroreflex sensitivity was reduced in depressed patients due to altered afferent and efferent component gains.
  • Antidepressant medications and depressed mood independently affected baroreflex sensitivity via the efferent pathway.

Conclusions:

  • Impairments in various baroreflex components and mechanisms are evident in depression.
  • These baroreflex alterations may contribute to the elevated cardiac risk observed in patients with major depressive disorder.
Abstract

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...